Your browser doesn't support javascript.
loading
Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.
Yoon, Jae-Ho; Min, Gi June; Park, Sung-Soo; Jeon, Young-Woo; Lee, Sung-Eun; Cho, Byung-Sik; Eom, Ki-Seong; Kim, Yoo-Jin; Kim, Hee-Je; Min, Chang-Ki; Cho, Seok-Goo; Kim, Dong-Wook; Lee, Jong Wook; Lee, Seok.
Afiliación
  • Yoon JH; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Min GJ; Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Park SS; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Jeon YW; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Lee SE; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Cho BS; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Eom KS; Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Kim YJ; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Kim HJ; Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Min CK; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Cho SG; Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Kim DW; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Lee JW; Leukemia Research Institute, College of Medicine, Catholic University of Korea, Seoul, Korea.
  • Lee S; Department of Hematology, Catholic Hematology Hospital, College of Medicine, Catholic University of Korea, Seoul, Korea.
Cancer ; 125(6): 873-883, 2019 03 15.
Article en En | MEDLINE | ID: mdl-30521062
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Neoplasia Residual / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Neoplasia Residual / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2019 Tipo del documento: Article